Analysts think DSM is fairly priced

DSM 's stock price seems, partly because of the recent share price rises, to be in line with most of the estimates. Most of the analysts say DSM is fairly priced now. Currently the company is being followed by 21 analysts. The average of the target prices for the stock is at 90,75 euros. This is more or less 0,74 percent more than the current price of 89,28 euros.

Few different opinions valuations DSM

Over the current book year the total revenue will be 9,34 billion euros (consensus estimates). This is slightly more than 2017's revenue of 8,63 billion euros.

Historical revenues and results DSM plus estimates 2018

The analysts expect for 2018 a net profit of 1,03 billion euros. The majority of the analysts expects for this year a profit per share of 5,83 euros. Based on this the price/earnings-ratio is 15,31.

Per share the analysts anticipate on a dividend of 1,99 euros per share. Thus the dividend yield equals 2,23 percent. The average dividend yield of the chemical companies equals a low 1 percent.

Latest estimates around 99 euros

UBS , Helvea Baader and Standard & Poors recently provided recommendations for the stock.

Based on the current number of outstanding shares DSM 's market capitalization 15,62 billion euros.

Historical stock prices DSM

At 9.17 the stock trades 0,02 percent higher at 89,28 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.